Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012022 · ClinicalTrials.gov registry record
Cleveland Heart and Metabolic Prevention Study
A clinical trial of Heart Failure Risk Factors in Healthy Individuals, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 1,208
- Enrollment target
- 1
- Study location
NCT03012022 is a study of Heart Failure Risk Factors in Healthy Individuals that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 1,208 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03012022, a study of Heart Failure Risk Factors in Healthy Individuals, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,208 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the role of chemical reactions, such as inflammation and oxidation, in the cause of cardiac dysfunction (the heart does not function properly). The investigators are interested in studying the various chemical pathways for cell damage to determine which are the most prevalent and/or most important. The investigators also want to determine whether waste products of oxidative damage or other chemicals can be monitored in the blood or urine and serve as an indication of the existence and severity of overall heart disease activity. The investigators further want to determine whether certain proteins, called enzymes, affect this cell damage, or whether the presence or absence of certain genes which create different forms of these enzymes correlate with the development of heart failure or cardiomyopathy (weakening of the heart muscle or a change in heart muscle structure) or other cardiovascular diseases.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,208 participants |
| Start Date | 2010-11-08 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03012022
The ClinicalTrials.gov registry entry for NCT03012022 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure Risk Factors in Healthy Individuals appearing as the primary indexed condition, and to 0 interventions.
NCT03012022 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03012022 about?
NCT03012022 is a clinical study titled "Cleveland Heart and Metabolic Prevention Study". The purpose of this research study is to investigate the role of chemical reactions, such as inflammation and oxidation, in the cause of cardiac dysfunction (the heart does not function properly). The investigators are interested in studying the various chemical pathways for cell damage to determine...
What is the current status of trial NCT03012022?
This trial is currently active not recruiting. The enrollment target is 1,208 participants. The study started on 2010-11-08. Estimated completion is 2026-12.
What conditions does trial NCT03012022 study?
This clinical trial studies the following conditions: Heart Failure Risk Factors in Healthy Individuals.
Who is sponsoring clinical trial NCT03012022?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03012022 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.